Cleared Traditional

Digital Blood Pressure Monitor WBP Series (K231542) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231542 · Weony (Shenzhen) Technology Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
100d
Days
Class 2
Risk

K231542 is an FDA 510(k) clearance for the Digital Blood Pressure Monitor WBP Series. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Weony (Shenzhen) Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on September 7, 2023 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Weony (Shenzhen) Technology Co., Ltd. devices

Submission Details

510(k) Number K231542 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2023
Decision Date September 07, 2023
Days to Decision 100 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 125d · This submission: 100d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 281
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K231542.
Boppli Infant Blood Pressure Monitor
K223873 · Pyrames, Inc. · Sep 2023
Wrist Electronic Blood Pressure Monitor(Model FC-BP200, FC-BP201, FC-BP210,FC-BP211, FC-BP220, FC-BP221)
K231367 · Shenzhen Finicare Co., Ltd. · Sep 2023
Arm Blood Pressure Monitor
K230649 · Alicn Medical (Shenzhen), Inc. · Sep 2023
Wrist Type Blood Pressure Monitor (W05,W1101L)
K230409 · Shenzhen Jamr Technology Co., Ltd. · Aug 2023
Arm-type Fully Automatic Digital Blood Pressure Monitor, Wrist-type Fully Automatic Digital Blood Pressure Monitor
K230566 · Joytech Healthcare Co. , Ltd. · Aug 2023
Electronic Blood Pressure Monitor
K230642 · Dongguan Kangweile Electronic Technology Co., Ltd. · Aug 2023